We uncovered that low-level activation of FOXO3 promotes cell growth under hypoxic conditions and tumor angiogenesis in vivo, whereas strong activation reduces tumor size and leads to deposition of extracellular matrix within the tumor tissue. This evidence concerns the gene FOXO3 and neoplasm.